Hydrogen Therapy Boosts Cancer Treatment by Improving Immune Response
- Authors
- Jing Huang, Jianping Meng, Yijie Fan, Engui Wang, Xiangxiang Wang, Huirun Fan, Dan Luo, Lingling Xu, Zhou Li
- Journal
- Materials Horizons
- Year
- 2025
- DOI
- 10.1039/d5mh00585j
- Study Type
- Mouse
- Outcome
- Positive
- Peer Reviewed
- Yes
- Country
- China
- Health Condition
- Cancer
- Body System
- Immune System
TL;DR
Hydrogen released from magnesium hydride boosts cancer cell death and immune response, making tumors more sensitive to checkpoint inhibitor therapy.
Key Finding
In mouse tumors, combining hydrogen gas therapy with sonodynamic therapy and immune checkpoint inhibitors significantly improved treatment effectiveness and extended survival compared to sound wave therapy alone.
Summary
Researchers tested a new cancer treatment approach in mice that combines hydrogen gas therapy with sound wave therapy (sonodynamic therapy). The hydrogen was released from magnesium hydride particles, which also produced alkaline compounds that reduced acidity in the tumor environment. This combination helped the immune system recognize and attack cancer cells more effectively, and made tumors more responsive to a type of immunotherapy called checkpoint inhibitors.
Practical Takeaway
This is early-stage research conducted only in mice, so it cannot yet be applied to human health. While the results suggest hydrogen gas may support certain cancer therapies by modifying the tumor environment, much more research—including human trials—would be needed before any clinical recommendations could be made.
Abstract
A combined therapeutic strategy (BUM) based on hydrogen therapy and sonodynamic therapy. MgH 2 -induced H 2 therapy could augment BTO-based SDT and enhance tumor therapeutic efficacy by modulating the TME.